Ibuprofen
Ibuprofen is a propionic acid-derived non-steroidal anti-inflammatory drug (NSAID) widely used for its analgesic, antipyretic, and anti-inflammatory properties.
Ibuprofen is a propionic acid-derived non-steroidal anti-inflammatory drug (NSAID) widely used for its analgesic, antipyretic, and anti-inflammatory properties. It exerts its pharmacological effects primarily through reversible inhibition of cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the biosynthesis of prostaglandins and thromboxanes involved in pain signaling, fever induction, and inflammatory cascades. Available in numerous formulations — including immediate-release tablets, lysinate salts, and sustained-release compositions — ibuprofen occupies a central role in both prescription and over-the-counter (OTC) pain and fever management, with non-prescription use typically capped at a maximum daily dose of 1,200 mg. Beyond its classical analgesic indication, ibuprofen has attracted sustained scientific interest for its potential utility in oncology, infectious disease, drug delivery, and environmental monitoring, positioning it as a molecularly versatile compound across multiple biomedical domains.
As a small-molecule NSAID, ibuprofen belongs to the same pharmacological class as indomethacin, naproxen, diclofenac, ketoprofen, and mefenamic acid — agents with which it is frequently compared in pharmacokinetic, ecological, and clinical studies. Its broad tissue distribution and relatively short half-life make formulation optimization an active area of pharmaceutical research, while its widespread consumption and incomplete environmental metabolism have established it as a prototypical pharmaceutical micropollutant of global concern.
Where the papers sit
13 papers from the last 6 months study ibuprofen directly · updated from PubMed 12 Nov 2026
Study type 1 clinical trial · 1 human data · 11 preclinical
Themes one subject
Those 13 are all about one subject.
-
Advanced Drug Formulation
Poor aqueous solubility and variable release are driving formulation strategies that improve ibuprofen dissolution, absorption, and dosing control. Hydrogels, chitosan nanoparticles, nanoemulsions, ionic liquids, amorphous solid dispersions, and lipid–polymer systems target enhanced delivery, including to skin and inflamed tissue. Sustained- and biphasic-release tablets are being refined through food-effect, pharmacokinetic, and scalable manufacturing studies. Analytical methods and 3D printing support quality control and individualized formulation design, but no single platform has emerged as dominant.
Papers
The 13 papers from the last 6 months that study ibuprofen directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Advanced Drug Formulation (13)
- Novel ibuprofen hydrogels self-assembled with biocompatible amino acids: mechanistic understanding and performance optimization. Physical chemistry chemical physics : PCCP · 20 Oct 2026 PMID 42899331
- Engineered Chitosan Nanoparticle Platform Enables Controlled Ibuprofen Delivery and Coordinated Neuroimmune Regulation in a Human Microphysiological Model. ACS applied bio materials · 18 Oct 2026 PMID 42892698
- Microfluidic processing of coarse emulsions: a scalable approach for nanoemulsion preparation in dermal drug delivery. International journal of pharmaceutics · 5 Sept 2026 PMID 42700904
- Novel Hybrid Polymer-Lipid-Based Formulations for Enhanced Dissolution Rates of Poorly Water-Soluble Drugs: A Quality by Design (QbD) Approach via Hot Melt Extrusion. AAPS PharmSciTech · 5 Sept 2026 PMID 42697982
- Microwave-Assisted Green Synthesis of Bi2O3Nanoparticles Using Artocarpus heterophyllus (Jack Fruit) Peel Extract for Efficient Photocatalytic Degradation of Pharmaceutical Contaminants. Chemistry & biodiversity · 31 Aug 2026 PMID 42673106
- Polydopamine/sodium alginate hydrogels with photothermal effects: a drug carrier for NIR-controlled drug release. Journal of materials chemistry. B · 29 Jul 2026 PMID 42525452
- Development of sustained-release oral tablets using xanthan and tragacanth gums as release modifiers. International journal of pharmaceutics · 23 Jul 2026 PMID 42492645
- Development of a Biphasic Modified-Release Ibuprofen Tablet Formulation: Single-Dose and Multiple-Dose Pharmacokinetics and Food-Effect Studies. Clinical and translational science · 30 Jun 2026 PMID 42374602
- Design of active pharmaceutical ingredient-ionic liquids for enhanced delivery to skin. Journal of controlled release : official journal of the Controlled Release Society · 27 Jun 2026 PMID 42364699
- Discovery of novel ibuprofen-1,3,4-thiadiazole derivatives attenuating ulcerative colitis by regulating MAPK-mediated inflammation and restoring intestinal immune homeostasis. European journal of medicinal chemistry · 21 Jun 2026 PMID 42323920
- Mechanistic prediction of food-induced variability in drug release and pharmacokinetics using a dynamic gastrointestinal system and convolution-based modeling. International journal of pharmaceutics · 19 Jun 2026 PMID 42320737
- A novel eco-friendly HPTLC approach for the simultaneous determination of erdosteine, ibuprofen and pseudoephedrine pharmaceutical combination. Scientific reports · 16 Jun 2026 PMID 42303778
- Evaluating FDM 3D printing and conventional tableting for producing ibuprofen amorphous solid dispersions. International journal of pharmaceutics · 30 May 2026 PMID 42217813
By study type
Clinical trials (1)
- Development of a Biphasic Modified-Release Ibuprofen Tablet Formulation: Single-Dose and Multiple-Dose Pharmacokinetics and Food-Effect Studies. Clinical and translational science · 30 Jun 2026 PMID 42374602
Human data, design not indexed (1)
- Engineered Chitosan Nanoparticle Platform Enables Controlled Ibuprofen Delivery and Coordinated Neuroimmune Regulation in a Human Microphysiological Model. ACS applied bio materials · 18 Oct 2026 PMID 42892698
Preclinical: animal, cell and lab studies (11)
- Novel ibuprofen hydrogels self-assembled with biocompatible amino acids: mechanistic understanding and performance optimization. Physical chemistry chemical physics : PCCP · 20 Oct 2026 PMID 42899331
- Microfluidic processing of coarse emulsions: a scalable approach for nanoemulsion preparation in dermal drug delivery. International journal of pharmaceutics · 5 Sept 2026 PMID 42700904
- Novel Hybrid Polymer-Lipid-Based Formulations for Enhanced Dissolution Rates of Poorly Water-Soluble Drugs: A Quality by Design (QbD) Approach via Hot Melt Extrusion. AAPS PharmSciTech · 5 Sept 2026 PMID 42697982
- Microwave-Assisted Green Synthesis of Bi2O3Nanoparticles Using Artocarpus heterophyllus (Jack Fruit) Peel Extract for Efficient Photocatalytic Degradation of Pharmaceutical Contaminants. Chemistry & biodiversity · 31 Aug 2026 PMID 42673106
- Polydopamine/sodium alginate hydrogels with photothermal effects: a drug carrier for NIR-controlled drug release. Journal of materials chemistry. B · 29 Jul 2026 PMID 42525452
- Development of sustained-release oral tablets using xanthan and tragacanth gums as release modifiers. International journal of pharmaceutics · 23 Jul 2026 PMID 42492645
- Design of active pharmaceutical ingredient-ionic liquids for enhanced delivery to skin. Journal of controlled release : official journal of the Controlled Release Society · 27 Jun 2026 PMID 42364699
- Discovery of novel ibuprofen-1,3,4-thiadiazole derivatives attenuating ulcerative colitis by regulating MAPK-mediated inflammation and restoring intestinal immune homeostasis. European journal of medicinal chemistry · 21 Jun 2026 PMID 42323920
- Mechanistic prediction of food-induced variability in drug release and pharmacokinetics using a dynamic gastrointestinal system and convolution-based modeling. International journal of pharmaceutics · 19 Jun 2026 PMID 42320737
- A novel eco-friendly HPTLC approach for the simultaneous determination of erdosteine, ibuprofen and pseudoephedrine pharmaceutical combination. Scientific reports · 16 Jun 2026 PMID 42303778
- Evaluating FDM 3D printing and conventional tableting for producing ibuprofen amorphous solid dispersions. International journal of pharmaceutics · 30 May 2026 PMID 42217813
Written from 13 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-07 by GPT. Drafted by language models from published abstracts; not medical advice.